Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP209885.RADahi3-HBq7MbJZLCyyoCTmjMOoaxkY4PAQ6EQ6OTLHY130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209885.RADahi3-HBq7MbJZLCyyoCTmjMOoaxkY4PAQ6EQ6OTLHY130_provenance.
• NP244505.RAce1kEEpui3HQUNNeRHAcPVrB3-E1UwPuXSP-Kc_DzuM130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244505.RAce1kEEpui3HQUNNeRHAcPVrB3-E1UwPuXSP-Kc_DzuM130_provenance.
• NP520851.RArPID_HYne2W3FUXWl0Z2Xv-FcwVl02_B38ShhoNIUbE130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520851.RArPID_HYne2W3FUXWl0Z2Xv-FcwVl02_B38ShhoNIUbE130_provenance.
• NP505395.RAfRY66H170IaZuQF_ZVrnVEL-Rws7Nc-I2AkvNA8Tb3o130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505395.RAfRY66H170IaZuQF_ZVrnVEL-Rws7Nc-I2AkvNA8Tb3o130_provenance.
• assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP510341.RA2uTr4XLLJQigcKapB0spveZbfZO-P2IbNu5rmr3mCLs130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP510341.RA2uTr4XLLJQigcKapB0spveZbfZO-P2IbNu5rmr3mCLs130_provenance.
• assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP659271.RA4wf2VtaoT_wjLiDKoFRQCltK4Hwm80Bw4YKRv1Lclas130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP659271.RA4wf2VtaoT_wjLiDKoFRQCltK4Hwm80Bw4YKRv1Lclas130_provenance.
• assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP840571.RAN0V3O4wRQF3Zn9dg3vkpp2qLx6IohLrbDyIDTlL97Zo130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP840571.RAN0V3O4wRQF3Zn9dg3vkpp2qLx6IohLrbDyIDTlL97Zo130_provenance.
• NP356603.RAS8W0NMdqdrujDcPhTLnLX8-rFUfkyN-S2B6HmDm1Qg0130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356603.RAS8W0NMdqdrujDcPhTLnLX8-rFUfkyN-S2B6HmDm1Qg0130_provenance.
• NP356606.RAWx0KxAAD9jqSgG9uGNkgY1KAt82a6SZSQJZYfNn_ZVo130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356606.RAWx0KxAAD9jqSgG9uGNkgY1KAt82a6SZSQJZYfNn_ZVo130_provenance.
• NP356610.RATo7X2oo5rKItlvAd5TjvY6iOmvxua576P308WEM1uEM130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356610.RATo7X2oo5rKItlvAd5TjvY6iOmvxua576P308WEM1uEM130_provenance.
• NP356612.RAbgcxZURJlTvHuZCOYKdfmw_N2yBfp2LTAjl503HtI08130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356612.RAbgcxZURJlTvHuZCOYKdfmw_N2yBfp2LTAjl503HtI08130_provenance.
• NP770568.RABlS_nTWqskqijaJ_QCvkVx0Gm_LJrExou2xqK5Ku5BI130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770568.RABlS_nTWqskqijaJ_QCvkVx0Gm_LJrExou2xqK5Ku5BI130_provenance.
• NP447744.RAludMpZKYlQt4QC8uP8hp8wd4yI96-Vo9DcpNrcyR_eU130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP447744.RAludMpZKYlQt4QC8uP8hp8wd4yI96-Vo9DcpNrcyR_eU130_provenance.
• NP356604.RAoMmaS9KnGUfF6kKIzeqx5DyUqiIsw03KWxsmb7OPOZk130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356604.RAoMmaS9KnGUfF6kKIzeqx5DyUqiIsw03KWxsmb7OPOZk130_provenance.
• NP398496.RAwrekpNv-583fiXvO3t0BGXW8ICG7ZR80_W0q1vm91J0130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP398496.RAwrekpNv-583fiXvO3t0BGXW8ICG7ZR80_W0q1vm91J0130_provenance.
• NP399948.RA4yoL0MG10zVYX53C3y6z66sd7MQVoVn7LpUDmKBxq1Q130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP399948.RA4yoL0MG10zVYX53C3y6z66sd7MQVoVn7LpUDmKBxq1Q130_provenance.
• NP497520.RAFS4h077v3z_CIJlESaepr1PceSk8I_cVe-HCVzx2N7Q130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP497520.RAFS4h077v3z_CIJlESaepr1PceSk8I_cVe-HCVzx2N7Q130_provenance.
• NP501179.RAGv7bw4WqBgE90doVzZuB92dJnik42nrjWauUaQ-F54c130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501179.RAGv7bw4WqBgE90doVzZuB92dJnik42nrjWauUaQ-F54c130_provenance.
• NP707452.RA_uory3_QGzDT1-pIVHWGro8kNANvzU9OFLj4n10t2ME130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP707452.RA_uory3_QGzDT1-pIVHWGro8kNANvzU9OFLj4n10t2ME130_provenance.
• NP356609.RA1qP1heo_Hj0P9TMuKP7Zg93G--75U-co9U3irs__cJg130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356609.RA1qP1heo_Hj0P9TMuKP7Zg93G--75U-co9U3irs__cJg130_provenance.
• NP356611.RA_QQn9aC_X6_KV3eJXlatYa_SUf_yaeIhtDhvEumKjKg130_assertion description "[To further elucidate the role of angiogenesis in the pathogenesis of chronic myelogenous leukemia (CML) we evaluated the effects of the bcr-abl translocation on the secretion of the angiogenic factors VEGF, FGF-2, HGF, IL-8 and matrix metalloproteinases (MMPs) as well as on the angiogenic potential in vivo of bcr-abl+ cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP356611.RA_QQn9aC_X6_KV3eJXlatYa_SUf_yaeIhtDhvEumKjKg130_provenance.